The University of Chicago Header Logo

Connection

Sudha Yarlagadda to Chemotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Sudha Yarlagadda has written about Chemotherapy, Adjuvant.
Sudha Yarlagadda
Connection Strength
0.052
Chemotherapy, Adjuvant
  1. Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial. JAMA Netw Open. 2025 Dec 01; 8(12):e2549109.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.